Some people with early, progressing Dupuytren’s disease may be considered for radiation therapy.
The first step is to ask your doctor whether a radiation oncology assessment makes sense for you.
This page provides general educational information and is not medical advice. Adaptiiv does not diagnose Dupuytren’s disease, determine whether radiation therapy is appropriate, or select a treatment provider. Diagnosis and treatment decisions must be made by qualified healthcare professionals. Product indications and availability vary by country.
Dupuytren's disease starts beneath the skin of the palm.
Dupuytren’s disease is a non-cancerous condition that affects the palmar fascia, a layer of tissue beneath the skin of the hand. It may begin as one or more firm lumps, called nodules. Over time, the tissue can thicken into cords that pull a finger toward the palm.
The course is different for everyone. Some nodules remain unchanged for years. Others grow, form cords, or gradually limit how far a finger can straighten.
Dupuytren’s Disease: The underlying condition.
Dupuytren’s Contracture: The later stage in which one or more fingers are fixed in a bent position.
A firm lump or thickened area in the palm.
A band of thickened tissue that can tighten over time.
A finger that can no longer fully straighten because a cord is pulling it inward.
The goal of RT is not to release a cord. It is to treat active tissue at a stage when a radiation oncologist believes there may be an opportunity to slow or stabilize the process.
Stable disease may only need observation. More advanced contracture usually calls for a hand-surgery assessment. Your age, health, disease pattern, previous treatment, and local clinical guidance also matter. Only a qualified clinician can determine whether RT is appropriate for you.
The team reviews your history, examines both hands, records nodules and cords,
measures finger movement, and looks for evidence of progression.
The affected tissue is marked on the skin. Some clinics use CT imaging and a
repeatable hand position to plan the treatment area and dose.
Common published schedules include 10 treatments given as two five-day courses
separated by several weeks, or seven treatments given over about two weeks.
Your schedule may be different.
Your team will explain how to care for the treated skin and how your hand will
be monitored after treatment.
A patient-specific bolus designed to the shape of your hand.
A bolus is a material placed on the skin during radiation therapy so the prescribed dose reaches tissue at or near the surface. The hand is a difficult area to fit: it is curved, irregular, and full of small spaces where a flat sheet can lift away from the skin.
TrueFit – Clear Bolus is a rigid, transparent, patient-matched device designed from imaging data in Adaptiiv 3D Bolus software. It is made for one patient and can be used throughout that patient’s treatment course.
Patient-specific geometry is intended to improve contact and minimize air gaps around a complex surface.
The care team can see the hand, skin markings, and alignment points through the bolus during setup.
The rigid design is intended to return to the planned position from one treatment visit to the next.
PUBLISHED CLINICAL EXPERIENCE
In his 2025 Practical Radiation Oncology publication, Dr. Yunes describes a CT-based workflow for treating Dupuytren’s disease with RT at UMass Chan Medical School–Baystate. The approach uses Adaptiiv 3D Bolus software to create custom 3D-printed modulated bolus, supporting reproducible setup where conventional sheet bolus can be difficult to position consistently.
For additional clinical context, Dr. Yunes’ article in Practical Radiation Oncology is available here.
This page provides general educational information and is not medical advice. Adaptiiv does not diagnose Dupuytren’s disease, determine whether radiation therapy is appropriate, or select a treatment provider. Diagnosis and treatment decisions must be made by qualified healthcare professionals. Product indications and availability vary by country.